This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
social distancing | 867 |
machine learning | 827 |
infectious diseases | 795 |
public health | 713 |
infectious disease | 689 |
sir model | 595 |
reproduction number | 577 |
time series | 574 |
deep learning | 562 |
author funder | 483 |
granted medrxiv | 483 |
copyright holder | 469 |
model parameters | 456 |
novel coronavirus | 454 |
neural networks | 438 |
cord uid | 435 |
doc id | 435 |
differential equations | 433 |
infected individuals | 415 |
neural network | 412 |
animal models | 405 |
made available | 392 |
version posted | 389 |
transmission rate | 381 |
optimal control | 376 |
total number | 363 |
international license | 352 |
seir model | 345 |
coronavirus disease | 345 |
epidemic model | 340 |
basic reproduction | 339 |
acute respiratory | 324 |
confirmed cases | 320 |
respiratory syndrome | 317 |
united states | 308 |
social media | 301 |
contact tracing | 300 |
population size | 298 |
climate change | 296 |
mathematical models | 290 |
incubation period | 287 |
based models | 279 |
infection rate | 278 |
data set | 273 |
epidemic models | 273 |
virus infection | 270 |
mathematical model | 258 |
severe acute | 248 |
disease transmission | 242 |
growth rate | 237 |
control measures | 233 |
stem cells | 229 |
transmission dynamics | 227 |
epidemiological models | 224 |
proposed model | 210 |
exponential growth | 209 |
total population | 208 |
death rate | 203 |
training data | 202 |
widely used | 201 |
animal model | 201 |
compartmental models | 200 |
peer review | 200 |
monte carlo | 198 |
susceptible individuals | 196 |
systemic risk | 196 |
learning models | 195 |
amino acid | 192 |
parameter values | 192 |
large number | 189 |
recovery rate | 189 |
intensive care | 187 |
reproductive number | 187 |
infected people | 186 |
results show | 178 |
based model | 177 |
drug discovery | 177 |
initial conditions | 176 |
herd immunity | 175 |
world health | 173 |
artificial intelligence | 172 |
medrxiv preprint | 170 |
immune response | 170 |
disease dynamics | 169 |
important role | 169 |
risk assessment | 169 |
infected cases | 169 |
pandemic influenza | 167 |
standard deviation | 166 |
systematic review | 165 |
mg kg | 165 |
training set | 164 |
new cases | 161 |
gene expression | 160 |
may also | 160 |
posted may | 160 |
cell lines | 159 |
model based | 159 |
per day | 159 |
case study | 158 |
prediction model | 157 |
social networks | 157 |
decision making | 156 |
data sets | 156 |
critical care | 156 |
health care | 154 |
prediction models | 154 |
two different | 153 |
health organization | 153 |
present study | 151 |
contact rate | 150 |
commonly used | 150 |
different types | 150 |
susceptible population | 149 |
convolutional neural | 148 |
tissue engineering | 146 |
disease spread | 146 |
virtual screening | 145 |
learning algorithms | 144 |
differential equation | 144 |
nan doi | 143 |
compartmental model | 140 |
real data | 140 |
even though | 140 |
random forest | 139 |
pharmaceutical interventions | 139 |
immune system | 138 |
available data | 138 |
federated learning | 136 |
symmetry breaking | 136 |
respiratory tract | 136 |
model using | 135 |
learning model | 135 |
data points | 135 |
test set | 135 |
mental health | 135 |
ordinary differential | 135 |
mathematical modeling | 134 |
linear regression | 133 |
south korea | 133 |
epithelial cells | 132 |
event prediction | 132 |
mouse model | 130 |
age group | 129 |
endemic equilibrium | 129 |
infectious individuals | 128 |
stem cell | 128 |
new york | 127 |
influenza virus | 127 |
human disease | 126 |
population density | 126 |
free equilibrium | 125 |
simulation model | 123 |
publicly available | 123 |
mortality rate | 122 |
previous studies | 122 |
cell types | 121 |
regression model | 121 |
different countries | 120 |
population dynamics | 120 |
risk factors | 119 |
time step | 119 |
social network | 119 |
infected individual | 119 |
public sentiment | 119 |
network models | 119 |
disease control | 119 |
energy system | 119 |
two models | 118 |
data analysis | 118 |
data streams | 118 |
markov chain | 118 |
disease outbreaks | 117 |
epidemiological model | 117 |
fake news | 117 |
real time | 116 |
basic reproductive | 116 |
syndrome coronavirus | 116 |
models using | 116 |
molecular dynamics | 116 |
sensitivity analysis | 116 |
data collection | 115 |
wide range | 115 |
see table | 115 |
influenza pandemic | 115 |
model selection | 114 |
model predictions | 113 |
disease progression | 113 |
network structure | 113 |
control strategies | 112 |
immune responses | 112 |
network model | 112 |
small number | 111 |
results obtained | 111 |
contact network | 110 |
results suggest | 110 |
transfer learning | 110 |
age groups | 110 |
bottleneck model | 110 |
average number | 110 |
rhesus macaques | 110 |
recent years | 109 |
latent period | 109 |
parameter estimates | 109 |
series data | 109 |
new infections | 108 |
cell culture | 108 |
new zealand | 108 |
big data | 108 |
simulation results | 108 |
table shows | 107 |
drug design | 106 |
different models | 106 |
endothelial cells | 105 |
data mining | 105 |
three different | 104 |
amino acids | 104 |
cumulative number | 104 |
upper airway | 104 |
also used | 103 |
parameter estimation | 103 |
respiratory syncytial | 103 |
experimental results | 103 |
ray images | 102 |
fractional order | 102 |
modelling study | 101 |
distancing measures | 101 |
models based | 101 |
real world | 101 |
guinea pigs | 100 |
mouse models | 100 |
fatality rate | 100 |
zika virus | 100 |
statistically significant | 100 |
first step | 99 |
syncytial virus | 99 |
future work | 99 |
logistic regression | 98 |
reported cases | 98 |
allows us | 98 |
growth factor | 98 |
protein structure | 98 |
rights reserved | 98 |
infected population | 98 |
infection risk | 98 |
deep neural | 97 |
sir models | 97 |
state variables | 97 |
probability distribution | 97 |
asymptotically stable | 97 |
time delay | 97 |
trained models | 95 |
surveillance data | 95 |
epidemic dynamics | 94 |
stock market | 93 |
cell line | 93 |
ebola virus | 93 |
unit time | 93 |
statistical analysis | 93 |
experimental data | 93 |
active cases | 92 |
blood flow | 92 |
allowed without | 92 |
knowledge graph | 92 |
bone tissue | 92 |
results indicate | 92 |
reuse allowed | 91 |
without permission | 91 |
model performance | 91 |
fractional derivative | 91 |
data sources | 90 |
contact networks | 90 |
using data | 90 |
decision tree | 90 |
mathematical modelling | 89 |
empirical data | 89 |
time period | 89 |
ct images | 89 |
policy makers | 89 |
based modeling | 88 |
mathematical theory | 88 |
support vector | 88 |
learning methods | 88 |
behaviour change | 88 |
may lead | 87 |
financial crisis | 87 |
nan sha | 87 |
bayesian model | 86 |
least one | 86 |
i i | 86 |
infectious period | 85 |
will also | 85 |
time interval | 85 |
sird model | 85 |
stage hli | 85 |
authors declare | 85 |
input data | 85 |
disease outbreak | 84 |
regression models | 84 |
models used | 84 |
best model | 84 |
simulation models | 84 |
based methods | 84 |
observed data | 84 |
maximum likelihood | 84 |
infection rates | 83 |
complex networks | 83 |
breast cancer | 83 |
free energy | 83 |
disease models | 83 |
side effects | 82 |
new model | 82 |
data assimilation | 82 |
viral load | 82 |
mechanistic models | 81 |
many countries | 81 |
artificial neural | 81 |
model fit | 81 |
avian influenza | 81 |
per unit | 80 |
effective reproduction | 80 |
one hand | 80 |
weight loss | 80 |
heart failure | 80 |
calculated using | 80 |
immunodeficiency virus | 80 |
become infected | 80 |
final model | 80 |
natural language | 79 |
hong kong | 79 |
inflammatory response | 79 |
glucose uptake | 79 |
simple model | 78 |
binding site | 78 |
recent studies | 78 |
posterior predictive | 78 |
crystal structure | 78 |
infected persons | 78 |
disease model | 78 |
model will | 78 |
incidence rate | 78 |
confidence interval | 77 |
computational models | 77 |
binding sites | 77 |
clinical signs | 77 |
loss function | 77 |
epidemic spreading | 77 |
generative model | 76 |
performed using | 76 |
predictive models | 76 |
model development | 76 |
mrna expression | 76 |
data used | 76 |
least squares | 76 |
data collected | 76 |
arima model | 76 |
statistical model | 76 |
two types | 75 |
closely related | 75 |
optimization problem | 75 |
saudi arabia | 75 |
severe disease | 75 |
box office | 75 |
oxidative stress | 75 |
initial condition | 75 |
social interactions | 75 |
steady state | 75 |
extracellular matrix | 75 |
also known | 75 |
care unit | 75 |
energy consumption | 75 |
global health | 74 |
new data | 74 |
model used | 74 |
second wave | 74 |
models may | 74 |
seir models | 74 |
early stages | 74 |
rheumatoid arthritis | 74 |
clinical trials | 73 |
reproduction numbers | 73 |
moving average | 73 |
mitigation strategies | 73 |
posterior distribution | 73 |
data stream | 73 |
recovered individuals | 73 |
long term | 72 |
trained model | 72 |
clinical features | 72 |
objective function | 72 |
first time | 72 |
better understanding | 72 |
decision makers | 72 |
nervous system | 72 |
epidemic curve | 71 |
literature review | 71 |
model systems | 71 |
symptom onset | 71 |
derived organoids | 71 |
mobility data | 70 |
nipah virus | 70 |
earth system | 70 |
high risk | 70 |
dengue virus | 70 |
transmission rates | 70 |
secondary structure | 70 |
cost function | 70 |
pluripotent stem | 70 |
risk prediction | 70 |
based approach | 70 |
next section | 70 |
systems biology | 70 |
cancer cells | 69 |
modeling approach | 69 |
viral replication | 69 |
different levels | 69 |
colorectal cancer | 69 |
air conditioning | 69 |
previous section | 69 |
different regions | 69 |
posted june | 68 |
epidemic spread | 68 |
death rates | 68 |
psychological distress | 68 |
hemorrhagic fever | 68 |
middle east | 68 |
linear model | 68 |
health interventions | 68 |
high level | 67 |
next generation | 67 |
social contact | 67 |
significantly reduced | 67 |
model assumes | 67 |
activation function | 67 |
sample size | 67 |
hiv aids | 66 |
contact patterns | 66 |
homology models | 66 |
final size | 66 |
modeling approaches | 66 |
model also | 66 |
relatively small | 66 |
cell death | 66 |
intervention strategies | 66 |
corona virus | 65 |
silico modeling | 65 |
plasma membrane | 65 |
numerical simulations | 65 |
wild type | 65 |
learning approach | 65 |
proposed models | 65 |
expected number | 65 |
sir epidemic | 65 |
current study | 65 |
dynamics simulations | 64 |
supplementary information | 64 |
infection dynamics | 64 |
early stage | 64 |
epidemiological parameters | 64 |
term memory | 64 |
reinforcement learning | 64 |
high levels | 64 |
learning rate | 64 |
epidemiological data | 64 |
time scale | 64 |
contact rates | 64 |
homogeneous mixing | 63 |
data available | 63 |
punching shear | 63 |
serious games | 63 |
exposed individuals | 63 |
control problem | 63 |
dna damage | 63 |
infected person | 63 |
model may | 63 |
short term | 63 |
confidence intervals | 63 |
drug development | 63 |
cynomolgus macaques | 63 |
test data | 63 |
historical data | 63 |
lockdown measures | 63 |
cohort study | 62 |
sequence alignment | 62 |
tumor cells | 62 |
creative commons | 62 |
grey verhulst | 62 |
model system | 62 |
human behavior | 62 |
future research | 62 |
chest ct | 62 |
large scale | 62 |
results showed | 62 |
bone marrow | 62 |
normal distribution | 62 |
significantly different | 62 |
equilibrium points | 62 |
respiratory distress | 62 |
hate speech | 61 |
inflection point | 61 |
sphere culture | 61 |
initial values | 61 |
west nile | 61 |
logistic model | 61 |
three models | 61 |
viral infection | 61 |
epidemic threshold | 61 |
starting point | 61 |
time points | 61 |
infected cells | 61 |
global stability | 61 |
comparative study | 61 |
verhulst model | 61 |
drug resistance | 60 |
bayesian inference | 60 |
clinical practice | 60 |
regression analysis | 60 |
icu beds | 60 |
data science | 60 |
existing models | 60 |
infection model | 60 |
likelihood function | 60 |
carrying capacity | 60 |
given time | 60 |
ground truth | 60 |
social support | 59 |
feature selection | 59 |
biological systems | 59 |
different time | 59 |
comparative modeling | 59 |
obtained using | 59 |
better performance | 59 |
sars coronavirus | 59 |
state space | 59 |
european countries | 59 |
statistical models | 59 |
infection cases | 59 |
adipose tissue | 59 |
computational modeling | 59 |
epidemic curves | 59 |
probability density | 59 |
three types | 59 |
respiratory disease | 59 |
exophiala dermatitidis | 59 |
cell proliferation | 58 |
similar results | 58 |
using deep | 58 |
fluid dynamics | 58 |
human mobility | 58 |
human population | 58 |
substitution model | 58 |
data using | 58 |
counterfactual explanations | 58 |
tissue culture | 58 |
clinical characteristics | 58 |
well known | 58 |
root mean | 58 |
east respiratory | 57 |
health status | 57 |
doubling time | 57 |
best fit | 57 |
emergency response | 57 |
using different | 57 |
prediction accuracy | 57 |
process model | 57 |
health system | 57 |
genetic algorithm | 57 |
fixed point | 57 |
decision trees | 57 |
homology model | 57 |
two groups | 57 |
target cells | 57 |
developing countries | 57 |
general equilibrium | 57 |
density function | 57 |
virus transmission | 57 |
cases per | 57 |
transgenic mice | 57 |
years old | 57 |
many different | 57 |
hospitalized patients | 57 |
taken together | 57 |
drug delivery | 56 |
positive cases | 56 |
surgical smoke | 56 |
molecular mechanisms | 56 |
compartment model | 56 |
decision support | 56 |
clinical disease | 56 |
dynamical systems | 56 |
equilibrium point | 56 |
ml based | 56 |
statistical methods | 56 |
also observed | 56 |
guinea pig | 56 |
maximum number | 56 |
relative humidity | 56 |
drug screening | 56 |
system dynamics | 56 |
prognostic models | 55 |
effective population | 55 |
point process | 55 |
disease modeling | 55 |
information criterion | 55 |
computational fluid | 55 |
large amount | 55 |
model training | 55 |
among others | 55 |
early dynamics | 55 |
classification model | 55 |
clinical data | 55 |
chain monte | 55 |
will lead | 55 |
often used | 55 |
lung cancer | 55 |
supplementary material | 55 |
stochastic epidemic | 55 |
recurrent neural | 55 |
boundary conditions | 55 |
case fatality | 55 |
best performance | 55 |
virus disease | 55 |
covariance matrix | 55 |
belief model | 54 |
two main | 54 |
feature extraction | 54 |
learning algorithm | 54 |
complex network | 54 |
training dataset | 54 |
recent advances | 54 |
long time | 54 |
deep convolutional | 54 |
intestinal organoids | 54 |
parameter space | 54 |
travel restrictions | 54 |
will become | 54 |
initial value | 54 |
body weight | 54 |
correlation coefficient | 54 |
mean square | 54 |
health belief | 54 |
cystic fibrosis | 54 |
computer vision | 53 |
spinal cord | 53 |
model counting | 53 |
susceptible people | 53 |
new approach | 53 |
better understand | 53 |
living cells | 53 |
raw data | 53 |
open source | 53 |
stochastic model | 53 |
human lung | 53 |
frequency domain | 53 |
uncertainty quantification | 53 |
dendritic cells | 52 |
time evolution | 52 |
transmission model | 52 |
linear models | 52 |
ion channels | 52 |
different values | 52 |
crucial role | 52 |
supervised learning | 52 |
many cases | 52 |
two weeks | 52 |
prediction results | 52 |
time dependent | 52 |
previous work | 52 |
biomedical research | 52 |
growth rates | 52 |
negative affect | 52 |
missing data | 52 |
next step | 52 |
pot model | 51 |
molecular docking | 51 |
symptomatic cases | 51 |
numerical simulation | 51 |
competing interests | 51 |
human health | 51 |
significantly higher | 51 |
test results | 51 |
sequence data | 51 |
dl model | 51 |
transcription factor | 51 |
daily cases | 51 |
medical resources | 51 |
secondary infections | 51 |
united kingdom | 51 |
case data | 51 |
disease modelling | 51 |
computational model | 51 |
time point | 51 |
surveillance systems | 51 |
job satisfaction | 51 |
infected patients | 51 |
seasonal influenza | 51 |
morning commute | 51 |
model parameter | 51 |
significant differences | 51 |
model results | 51 |
sis model | 51 |
stochastic models | 50 |
findings suggest | 50 |
recovered cases | 50 |
reported data | 50 |
dependent manner | 50 |
key samples | 50 |
health policy | 50 |
risk management | 50 |
vaccination strategies | 50 |
human diseases | 50 |
allow us | 50 |
vector machine | 50 |
active site | 50 |
may help | 50 |
sequence identity | 50 |
human immunodeficiency | 50 |
health problems | 50 |
west africa | 50 |
economic impact | 50 |
epidemic outbreak | 50 |
one may | 50 |
encephalitis virus | 50 |
random variable | 50 |
culture model | 50 |
will use | 50 |
significantly increased | 50 |
emerging infectious | 50 |
first case | 50 |
models will | 50 |
school closures | 50 |
target protein | 50 |
voter model | 49 |
may provide | 49 |
recent study | 49 |
mouth disease | 49 |
model uses | 49 |
different stages | 49 |
related events | 49 |
classification models | 49 |
coronavirus infection | 49 |
input variables | 49 |
first days | 49 |
human brain | 49 |
material model | 49 |
exit strategies | 49 |
lstm model | 49 |
cell surface | 49 |
mixing patterns | 49 |
diagnostic markers | 49 |
western blot | 49 |
simulated data | 49 |
social isolation | 49 |
two parameters | 49 |
million people | 49 |
complex systems | 49 |
hospital admission | 49 |
model calibration | 49 |
membrane proteins | 49 |
risk perception | 49 |
analysis using | 49 |
will need | 48 |
predictive model | 48 |
smooth muscle | 48 |
genetic programming | 48 |
small molecules | 48 |
forecasting models | 48 |
healthcare demand | 48 |
ng ml | 48 |
death toll | 48 |
network theory | 48 |
signal transduction | 48 |
infectious individual | 48 |
susceptible individual | 48 |
based approaches | 48 |
structure prediction | 48 |
two distinct | 48 |
may occur | 48 |
short time | 48 |
time course | 48 |
crispr cas | 48 |
preventive behaviors | 48 |
first two | 48 |
language processing | 48 |
single model | 47 |
i will | 47 |
open access | 47 |
natural history | 47 |
nonlinear incidence | 47 |
systemic risks | 47 |
logistic growth | 47 |
per year | 47 |
random network | 47 |
risk amplification | 47 |
coronavirus outbreak | 47 |
stability analysis | 47 |
validation set | 47 |
partial differential | 47 |
innate immune | 47 |
fully connected | 47 |
protein expression | 47 |
series models | 47 |
mitigation measures | 47 |
shear stress | 47 |
gradient descent | 47 |
model without | 47 |
fractional differential | 47 |
deficient mice | 47 |
spatial heterogeneity | 47 |
virus spread | 47 |
random variables | 46 |
qsar models | 46 |
discrete time | 46 |
dependent variable | 46 |
mathematical epidemiology | 46 |
new coronavirus | 46 |
total cases | 46 |
mass spectrometry | 46 |
may vary | 46 |
much higher | 46 |
epidemic control | 46 |
posted april | 46 |
time varying | 46 |
domain images | 46 |
volatility models | 46 |
study period | 46 |
dna sequences | 46 |
financial markets | 46 |
mean value | 46 |
predictive power | 46 |
cancer cell | 46 |
future studies | 46 |
model predicts | 46 |
significant impact | 46 |
reduce covid | 46 |
series forecasting | 46 |
model evidence | 46 |
type i | 46 |
mean absolute | 46 |
clock model | 45 |
model structure | 45 |
confirmed covid | 45 |
learning techniques | 45 |
mechanical properties | 45 |
com scientificreports | 45 |
generalized logistic | 45 |
target cell | 45 |
negative binomial | 45 |
node i | 45 |
every day | 45 |
based drug | 45 |
disease will | 45 |
social structure | 45 |
social interaction | 45 |
computational methods | 45 |
containment measures | 45 |
data scientists | 45 |
across different | 45 |
care units | 45 |
logistic function | 45 |
latent space | 45 |
pulmonary disease | 45 |
spatial resolution | 45 |
small animal | 45 |
high degree | 45 |
clock models | 45 |
culture system | 45 |
comparative models | 45 |
departure time | 45 |
effective distance | 45 |
exposure notification | 45 |
human respiratory | 45 |
base pairs | 45 |
ex vivo | 45 |
sequence space | 44 |
random graphs | 44 |
limited number | 44 |
model provides | 44 |
molecular weight | 44 |
environmental factors | 44 |
within days | 44 |
biogeochemical models | 44 |
genetic diversity | 44 |
image classification | 44 |
feature engineering | 44 |
international spread | 44 |
human genome | 44 |
multiple sclerosis | 44 |
frequently used | 44 |
meta model | 44 |
best accuracy | 44 |
unknown parameters | 44 |
equine encephalitis | 44 |
physical distancing | 44 |
dynamic models | 44 |
antimicrobial peptides | 44 |
additional file | 44 |
heart disease | 44 |
first wave | 44 |
dynamic model | 44 |
spatial distribution | 44 |
supply chain | 44 |
wide variety | 44 |
dnn model | 44 |
highly pathogenic | 44 |
symptomatic individuals | 44 |
severe cases | 44 |
first order | 44 |
molecular modeling | 44 |
see section | 44 |
current state | 44 |
aqueous humor | 44 |
sleep apnea | 44 |
original data | 44 |
present work | 44 |
frequency volatility | 44 |
different scenarios | 43 |
prior knowledge | 43 |
temporal resolution | 43 |
several studies | 43 |
chronic obstructive | 43 |
take place | 43 |
convolutional networks | 43 |
see also | 43 |
wage workers | 43 |
springer nature | 43 |
viral shedding | 43 |
gradient boosting | 43 |
relatively low | 43 |
median age | 43 |
predictive value | 43 |
biological activity | 43 |
homology modelling | 43 |
model fitting | 43 |
recent work | 43 |
modeling infectious | 43 |
prediction performance | 43 |
prediction using | 43 |
organoids derived | 43 |
one needs | 43 |
approach based | 43 |
determine whether | 43 |
global pandemic | 43 |
medical data | 43 |
hendra virus | 43 |
patients infected | 43 |
richards model | 43 |
lower respiratory | 43 |
key role | 43 |
lung injury | 43 |
models trained | 43 |
driven models | 42 |
electronic health | 42 |
transition probabilities | 42 |
posted july | 42 |
respiratory diseases | 42 |
section presents | 42 |
error bars | 42 |
future events | 42 |
training process | 42 |
nile virus | 42 |
cnn model | 42 |
results demonstrate | 42 |
make predictions | 42 |
conceptual model | 42 |
organoid cultures | 42 |
squared error | 42 |
face masks | 42 |
fractional calculus | 42 |
deterministic model | 42 |
ml models | 42 |
quantitative structure | 42 |
healthcare system | 42 |
daily deaths | 42 |
make use | 42 |
human airway | 42 |
convolutional layers | 42 |
cov infection | 42 |
early phase | 42 |
will continue | 42 |
hand side | 42 |
risk analysis | 42 |
biological processes | 42 |
drug candidates | 42 |
obstructive sleep | 42 |
input parameters | 42 |
specific model | 42 |
growth factors | 42 |
becoming infected | 42 |
airborne transmission | 42 |
proposed approach | 42 |
infectious dose | 42 |
continuous time | 42 |
blood pressure | 42 |
epidemic outbreaks | 41 |
several countries | 41 |
epidemic size | 41 |
may cause | 41 |
less likely | 41 |
published maps | 41 |
nitric oxide | 41 |
ensemble models | 41 |
dynamic causal | 41 |
remains neutral | 41 |
inflammatory diseases | 41 |
programming language | 41 |
comparative analysis | 41 |
lancet infectious | 41 |
type ii | 41 |
potential impact | 41 |
drug repurposing | 41 |
complex models | 41 |
various countries | 41 |
batch size | 41 |
jurisdictional claims | 41 |
nature remains | 41 |
institutional affiliations | 41 |
also found | 41 |
square error | 41 |
conditional probability | 41 |
various types | 41 |
pathogen transmission | 41 |
data transfer | 41 |
much larger | 41 |
random effects | 41 |
data may | 41 |
hospital capacity | 41 |
protein sequences | 41 |
data augmentation | 41 |
vice versa | 41 |
lassa fever | 41 |
health measures | 41 |
birth rate | 41 |
additional information | 41 |
become available | 41 |
gamma distribution | 40 |
asymptomatic cases | 40 |
percentage error | 40 |
school closure | 40 |
rapidly evolving | 40 |
class i | 40 |
poisson distribution | 40 |
predictive performance | 40 |
high quality | 40 |
upper bound | 40 |
molecular clock | 40 |
different kinds | 40 |
many people | 40 |
news detection | 40 |
laboratory animals | 40 |
evaluated using | 40 |
knockout mice | 40 |
classification accuracy | 40 |
significant difference | 40 |
relatively large | 40 |
data suggest | 40 |
protein interactions | 40 |
system model | 40 |
cell viability | 40 |
travel time | 40 |
preventive behavior | 40 |
four different | 40 |
experimental infection | 40 |
species distribution | 40 |
lymph nodes | 40 |
working conditions | 40 |
referenced ti | 40 |
electron microscopy | 40 |
mean squared | 40 |
promising results | 40 |
significantly lower | 40 |
data point | 40 |
high performance | 40 |
conformational changes | 40 |
better results | 40 |
cell membrane | 40 |
may result | 40 |
johns hopkins | 40 |
dl models | 40 |
ct scans | 40 |
life satisfaction | 40 |
growth model | 40 |
epidemic modeling | 40 |
binary classification | 40 |
per capita | 40 |
growth curve | 40 |
population level | 40 |
forecasting model | 40 |
serial interval | 40 |
model prediction | 40 |
high accuracy | 39 |
model comparison | 39 |
degree distribution | 39 |
binding protein | 39 |
one another | 39 |
expected value | 39 |
type diabetes | 39 |
protein kinase | 39 |
electrical load | 39 |
monkeypox virus | 39 |
image segmentation | 39 |
mf prevalence | 39 |
york city | 39 |
hiv infection | 39 |
locally asymptotically | 39 |
random walk | 39 |
experimental model | 39 |
mortality rates | 39 |
health authorities | 39 |
asymptomatic individuals | 39 |
best results | 39 |
viral infections | 39 |
will help | 39 |
independent variables | 39 |
fixed effects | 39 |
word embedding | 39 |
coronavirus pandemic | 39 |
another important | 39 |
tumor growth | 39 |
using machine | 39 |
near future | 39 |
allowed us | 39 |
obstructive pulmonary | 39 |
actual data | 39 |
dengue fever | 39 |
epithelial cell | 39 |
classification tasks | 38 |
different ways | 38 |
social mixing | 38 |
attention mechanism | 38 |
entire population | 38 |
data obtained | 38 |
global model | 38 |
first one | 38 |
temporal dynamics | 38 |
attack rate | 38 |
model evaluation | 38 |
preventive measures | 38 |
physiological parameters | 38 |
air travel | 38 |
reproduction rate | 38 |
north america | 38 |
new models | 38 |
three main | 38 |
prediction methods | 38 |
optimal solution | 38 |
proposed method | 38 |
clinically relevant | 38 |
net benefit | 38 |
every time | 38 |
information regarding | 38 |
also called | 38 |
disease free | 38 |
side chains | 38 |
sequence length | 38 |
hubei province | 38 |
hybrid model | 38 |
will die | 38 |
learning process | 38 |
central nervous | 38 |
test dataset | 38 |
office prediction | 38 |
intake dose | 38 |
deterministic models | 38 |
exponential smoothing | 38 |
based simulation | 38 |
extreme losses | 38 |
currently available | 38 |
another study | 38 |
drug targets | 38 |
individuals may | 38 |
backward bifurcation | 38 |
relatively high | 38 |
cellular automata | 38 |
brain injury | 38 |
predictor variables | 38 |
finite element | 38 |
coupled receptors | 38 |
based modelling | 37 |
learning based | 37 |
simple models | 37 |
get infected | 37 |
aedes aegypti | 37 |
susceptible class | 37 |
anterior chamber | 37 |
face mask | 37 |
object detection | 37 |
adverse effects | 37 |
influenza viruses | 37 |
signaling pathways | 37 |
drug administration | 37 |
infection will | 37 |
social contacts | 37 |
actual number | 37 |
adaptive immune | 37 |
turning point | 37 |
acid sequence | 37 |
exchange rate | 37 |
survey data | 37 |
air quality | 37 |
dynamical system | 37 |
flow cytometry | 37 |
hidden markov | 37 |
disease spreading | 37 |
tax evasion | 37 |
disease surveillance | 37 |
also shows | 37 |
target proteins | 37 |
characteristic equation | 37 |
time intervals | 37 |
model averaging | 37 |
worth noting | 37 |
immune cells | 37 |
hospital beds | 37 |
cell type | 37 |
also show | 37 |
medical image | 37 |
epidemic growth | 37 |
lipid bilayer | 37 |
bayesian analysis | 37 |
viral rna | 37 |
control theory | 37 |
contacts per | 37 |
large population | 37 |
skeletal muscle | 37 |
van der | 37 |
compartment models | 37 |
model validation | 37 |
time horizon | 37 |
metapopulation models | 37 |
see appendix | 37 |
transmission models | 37 |
word embeddings | 37 |
target sequence | 36 |
may affect | 36 |
model discrimination | 36 |
section describes | 36 |
brain tumor | 36 |
measures taken | 36 |
trained using | 36 |
vector machines | 36 |
test statistic | 36 |
health emergency | 36 |
small molecule | 36 |
genetically modified | 36 |
organoid culture | 36 |
economic growth | 36 |
blood vessels | 36 |
inverse problem | 36 |
note springer | 36 |
direct contact | 36 |
long short | 36 |
significant effect | 36 |
inflammatory cytokines | 36 |
normally distributed | 36 |
data subset | 36 |
learning approaches | 36 |
based analysis | 36 |
second order | 36 |
growth models | 36 |
escherichia coli | 36 |
validation cohort | 36 |
cell cultures | 36 |
exposed people | 36 |
protein sequence | 36 |
second step | 36 |
will allow | 36 |
quite different | 36 |
diffusion model | 36 |
health systems | 36 |
included studies | 36 |
another example | 36 |
mice subjected | 36 |
credible intervals | 36 |
model allows | 36 |
traffic congestion | 36 |
relatively simple | 36 |
precision medicine | 36 |
methods used | 36 |
spatial structure | 36 |
life cycle | 36 |
people will | 36 |
good agreement | 36 |
population sizes | 36 |
may become | 36 |
much better | 36 |
business model | 36 |
human upper | 36 |
computational cost | 36 |
marine biogeochemical | 36 |
fever virus | 35 |
cell cycle | 35 |
mice infected | 35 |
using three | 35 |
generation rate | 35 |
different times | 35 |
models developed | 35 |
protein structures | 35 |
case duration | 35 |
temporal networks | 35 |
estimated using | 35 |
computer science | 35 |
environmental conditions | 35 |
network analysis | 35 |
ml methods | 35 |
patient care | 35 |
multiple sequence | 35 |
will focus | 35 |
increased risk | 35 |
general public | 35 |
upper respiratory | 35 |
will show | 35 |
time periods | 35 |
large numbers | 35 |
based method | 35 |
people infected | 35 |
homology modeling | 35 |
west african | 35 |
virus infections | 35 |
general population | 35 |
short period | 35 |
new method | 35 |
second level | 35 |
models provide | 35 |
diffusion process | 35 |
lstm models | 35 |
low level | 35 |
among different | 35 |
marginal likelihood | 35 |
primary human | 35 |
control group | 35 |
ion channel | 35 |
risk factor | 35 |
action control | 35 |
cases will | 34 |
microblogging marketing | 34 |
culture models | 34 |
performance evaluation | 34 |
imperial college | 34 |
varying parameters | 34 |
flat slabs | 34 |
census data | 34 |
effective reproductive | 34 |
congestion pricing | 34 |
model presented | 34 |
qsar model | 34 |
model proposed | 34 |
distress syndrome | 34 |
probability distributions | 34 |
health behaviors | 34 |
become infectious | 34 |
information flow | 34 |
will increase | 34 |
space model | 34 |
functional form | 34 |
peripheral blood | 34 |
icu patients | 34 |
risk group | 34 |
maximum value | 34 |
rabbit model | 34 |
current situation | 34 |
frequency data | 34 |
metabolic engineering | 34 |
us consider | 34 |
dynamic system | 34 |
pattern recognition | 34 |
bayesian approach | 34 |
model assumptions | 34 |
accurate predictions | 34 |
community structure | 34 |
model building | 34 |
hybrid models | 34 |
mass action | 34 |
special case | 34 |
statistical inference | 34 |
population will | 34 |
family members | 34 |
localisation lengths | 34 |
infection age | 34 |
lung tissue | 34 |
death cases | 34 |
infected class | 34 |
load prediction | 34 |
ray crystallography | 34 |
vaccination rate | 34 |
quanta generation | 34 |
necessary conditions | 34 |
silico pharmacology | 34 |
game theory | 34 |
collected data | 34 |
novel approach | 34 |
infectious particles | 34 |
contact parameter | 33 |
oxygen saturation | 33 |
acid residues | 33 |
clinical symptoms | 33 |
prior distributions | 33 |
fitness landscape | 33 |
link prediction | 33 |
initial number | 33 |
reported confirmed | 33 |
model i | 33 |
control variables | 33 |
useful tool | 33 |
nonhuman primates | 33 |
hopkins university | 33 |
two parts | 33 |
statistical significance | 33 |
retrospective cohort | 33 |
cumulative deaths | 33 |
one model | 33 |
online social | 33 |
generation matrix | 33 |
study design | 33 |
change theories | 33 |
fractional derivatives | 33 |
significant increase | 33 |
rapid spread | 33 |
system models | 33 |
i th | 33 |
breaking predicates | 33 |
increasing number | 33 |
rat model | 33 |
implemented using | 33 |
series analysis | 33 |
ode model | 33 |
reproduction ratio | 33 |
also present | 33 |
agent based | 33 |
different classes | 33 |
see text | 33 |
adrenergic receptor | 33 |
user interface | 33 |
key parameters | 33 |
right side | 33 |
resource allocation | 33 |
important factor | 33 |
carlo simulation | 33 |
critical role | 33 |
give rise | 33 |
threshold value | 33 |
distribution function | 33 |
molecular level | 33 |
parameters used | 33 |
control problems | 33 |
modelling approach | 33 |
diamond princess | 33 |
results presented | 33 |
adverse events | 33 |
much smaller | 33 |
supplementary table | 33 |
stochastic sir | 32 |
new insights | 32 |
lung disease | 32 |
model described | 32 |
making process | 32 |
table presents | 32 |
body temperature | 32 |
confusion matrix | 32 |
kalman filter | 32 |
organic farming | 32 |
large enough | 32 |
lower bound | 32 |
risk perceptions | 32 |
multilayer networks | 32 |
two classes | 32 |
will provide | 32 |
sample sizes | 32 |
determined using | 32 |
assessed using | 32 |
takes place | 32 |
case counts | 32 |
sars epidemic | 32 |
data availability | 32 |
valley fever | 32 |
sign epistasis | 32 |
surface area | 32 |
case numbers | 32 |
model accuracy | 32 |
one week | 32 |
high affinity | 32 |
structural identifiability | 32 |
specific models | 32 |
daily new | 32 |
flow diagram | 32 |
epidemic data | 32 |
distancing behavior | 32 |
use change | 32 |
culture conditions | 32 |
embryonic stem | 32 |
hli model | 32 |
european union | 32 |
term forecasts | 32 |
demographic data | 32 |
shear capacity | 32 |
another approach | 32 |
causal tree | 32 |
viral disease | 32 |
graph completion | 32 |
human transmission | 32 |
order model | 32 |
rift valley | 32 |
previous study | 31 |
past behavior | 31 |
march th | 31 |
crystal structures | 31 |
human infection | 31 |
hev spillover | 31 |
lung diseases | 31 |
recovery rates | 31 |
transgenic pigs | 31 |
world data | 31 |
air pollution | 31 |
coronavirus covid | 31 |
type mice | 31 |
limited data | 31 |
jacobian matrix | 31 |
surveillance system | 31 |
exponentially distributed | 31 |
predictive ability | 31 |
animal species | 31 |
death counts | 31 |
health outcomes | 31 |
receptor activation | 31 |
will discuss | 31 |
real economy | 31 |
term predictions | 31 |
level model | 31 |
daily data | 31 |
infected pneumonia | 31 |
first equation | 31 |
coronavirus pneumonia | 31 |
binding affinity | 31 |
useful information | 31 |
time delays | 31 |
large animal | 31 |
computer simulations | 31 |
integrated moving | 31 |
arrival time | 31 |
optimization problems | 31 |
iede model | 31 |
using multiple | 31 |
nonhuman primate | 31 |
help us | 31 |
standard deviations | 31 |
sequence similarity | 31 |
computational approaches | 31 |
current covid | 31 |
significant role | 31 |
prior distribution | 31 |
one day | 31 |
ensemble learning | 31 |
humanized mice | 31 |
mathematical analysis | 31 |
becomes available | 31 |
base pair | 31 |
base model | 31 |
also showed | 31 |
dynamical processes | 31 |
muscle cells | 31 |
reactive oxygen | 31 |
empirical studies | 31 |
individuals will | 31 |
also includes | 31 |
infectious agents | 31 |
two nodes | 31 |
word vec | 31 |
branch lengths | 31 |
membrane protein | 31 |
particularly important | 31 |
value creation | 31 |
model consists | 31 |
new infection | 31 |
influenza epidemic | 31 |
related work | 31 |
rhesus monkeys | 31 |
phase ii | 31 |
model shows | 31 |
recent data | 31 |
using two | 31 |
test sets | 30 |
response strategies | 30 |
structural features | 30 |
sexually transmitted | 30 |
may need | 30 |
target data | 30 |
optic nerve | 30 |
receiver operating | 30 |
incremental learning | 30 |
population structure | 30 |
days postinfection | 30 |
objective optimization | 30 |
parsimonious model | 30 |
chemical descriptors | 30 |
online learning | 30 |
randomly chosen | 30 |
global spread | 30 |
airborne pathogens | 30 |
binomial distribution | 30 |
posted october | 30 |
validation data | 30 |
cruise ship | 30 |
two cases | 30 |
modified seir | 30 |
current data | 30 |
gaussian distribution | 30 |
classification using | 30 |
care system | 30 |
infection curve | 30 |
protein function | 30 |
first model | 30 |
individuals infected | 30 |
therapeutic strategies | 30 |
media platforms | 30 |
two years | 30 |
different states | 30 |
initial infection | 30 |
main proteinase | 30 |
models like | 30 |
based systems | 30 |
model achieved | 30 |
will remain | 30 |
medical imaging | 30 |
pulmonary fibrosis | 30 |
method used | 30 |
image analysis | 30 |
enables us | 30 |
us states | 30 |
initial state | 30 |
human contact | 30 |
model checking | 30 |
naturally occurring | 30 |
policy decisions | 30 |
disease caused | 30 |
model performs | 30 |
progenitor cells | 30 |
model given | 30 |
conditioning system | 30 |
important features | 30 |
inflammatory responses | 30 |
explanatory power | 30 |
computational science | 30 |
live poultry | 30 |
using bayesian | 30 |
point processes | 30 |
days ahead | 30 |
central air | 30 |
classification performance | 30 |
necrosis factor | 30 |
higher levels | 30 |
household isolation | 29 |
human behaviour | 29 |
removal rate | 29 |
causal modelling | 29 |
numerical results | 29 |
human liver | 29 |
model fits | 29 |
dna repair | 29 |
technical report | 29 |
predict future | 29 |
left panel | 29 |
one possible | 29 |
population growth | 29 |
rate constants | 29 |
model complexity | 29 |
information systems | 29 |
substitution models | 29 |
model construction | 29 |
also consider | 29 |
expression levels | 29 |
land application | 29 |
exponential model | 29 |
theoretical model | 29 |
mobile phone | 29 |
susceptible person | 29 |
stochastic process | 29 |
ebola outbreak | 29 |
molecular biology | 29 |
false positive | 29 |
bl mice | 29 |
predicted values | 29 |
human intestinal | 29 |
cardiovascular disease | 29 |
source code | 29 |
health records | 29 |
testing data | 29 |
financial system | 29 |
uniform distribution | 29 |
numerical methods | 29 |
mouse strains | 29 |
future event | 29 |
cell growth | 29 |
viral particles | 29 |
silico models | 29 |
search space | 29 |
panel data | 29 |
much less | 29 |
th march | 29 |
optimization algorithm | 29 |
pattern formation | 29 |
will occur | 29 |
chemical reactions | 29 |
different groups | 29 |
density functional | 29 |
human cases | 29 |
evaluation metrics | 29 |
cancer research | 29 |
fitness landscapes | 29 |
positive affect | 29 |
data analytics | 29 |
least square | 29 |
model showed | 29 |
following two | 29 |
posterior distributions | 29 |
disease course | 29 |
york times | 29 |
different aspects | 29 |
strand breaks | 29 |
genome sequence | 29 |
oc problem | 29 |
ncov outbreak | 29 |
data will | 29 |
side chain | 29 |
force field | 29 |
mc model | 29 |
low risk | 29 |
nonpharmaceutical interventions | 29 |
computed tomography | 29 |
change points | 29 |
quarantine measures | 29 |
optimal controls | 29 |
active infections | 29 |
mainland china | 29 |
text classification | 29 |
first reported | 29 |
studies using | 29 |
also important | 29 |
future directions | 29 |
recommendation framework | 29 |
blood cell | 29 |
mrna levels | 29 |
reverse transcriptase | 29 |
princess cruise | 29 |
predictive distribution | 29 |
gives us | 29 |
communicable diseases | 29 |
highly significant | 28 |
posterior probability | 28 |
urban areas | 28 |
infectious person | 28 |
also provide | 28 |
prediction error | 28 |
high throughput | 28 |
nhp models | 28 |
airborne particles | 28 |
structural information | 28 |
statistical computing | 28 |
activity relationship | 28 |
mean field | 28 |
uppaal stratego | 28 |
kinase inhibitors | 28 |
days later | 28 |
april th | 28 |
different methods | 28 |
intervention measures | 28 |
two approaches | 28 |
stable equilibrium | 28 |
reliable data | 28 |
cancer organoids | 28 |
outbreak prediction | 28 |
polymicrobial diseases | 28 |
single molecule | 28 |
poorly understood | 28 |
studied using | 28 |
took place | 28 |
lipid bilayers | 28 |
coordinate system | 28 |
data access | 28 |
tumor volume | 28 |
southeast asia | 28 |
globally asymptotically | 28 |
vertical transmission | 28 |
much lower | 28 |
using artificial | 28 |
home order | 28 |
exponential distribution | 28 |
powerful tool | 28 |
domestic cat | 28 |
akaike information | 28 |
unreported cases | 28 |
daily number | 28 |
country level | 28 |
endemic equilibria | 28 |
heart rate | 28 |
two independent | 28 |
economic crisis | 28 |
situation report | 28 |
daily growth | 28 |
different locations | 28 |
consider two | 28 |
external validation | 28 |
predicted value | 28 |
will always | 28 |
time markov | 28 |
integer order | 28 |
two categories | 28 |
health officials | 28 |
perceived susceptibility | 28 |
genetic algorithms | 28 |
prescriptive analytics | 28 |
constant rate | 28 |
phase transition | 28 |
right panel | 28 |
working memory | 28 |
predictions made | 28 |
age structure | 28 |
care utilization | 28 |
high resolution | 28 |
blood cells | 28 |
sierra leone | 28 |
seir epidemic | 28 |
natural death | 28 |
control strategy | 28 |
host cells | 27 |
tumor organoids | 27 |
vaccine development | 27 |
structure determination | 27 |
knowledge graphs | 27 |
studies indicate | 27 |
system modeling | 27 |
seiqr model | 27 |
operating room | 27 |
monoclonal antibody | 27 |
long period | 27 |
basis function | 27 |
zika fever | 27 |
similar way | 27 |
power law | 27 |
age class | 27 |
carbon energy | 27 |
using real | 27 |
model date | 27 |
bone graft | 27 |
diseases like | 27 |
scoring functions | 27 |
weighted average | 27 |
total deaths | 27 |
mg ml | 27 |
cell biology | 27 |
oxygen species | 27 |
experimental models | 27 |
st century | 27 |
may still | 27 |
digital exposure | 27 |
standard theory | 27 |
absolute percentage | 27 |
highly dependent | 27 |
magnetic resonance | 27 |
likelihood estimation | 27 |
mechanisms underlying | 27 |
basic model | 27 |
models predict | 27 |
infectious people | 27 |
stochastic gradient | 27 |
model predicted | 27 |
wearing masks | 27 |
medical question | 27 |
murine model | 27 |
democratic republic | 27 |
image recognition | 27 |
protective measures | 27 |
large amounts | 27 |
github repository | 27 |
phylodynamic methods | 27 |
sequential order | 27 |
healthcare buildings | 27 |
human organoids | 27 |
spike protein | 27 |
human pluripotent | 27 |
vaccination coverage | 27 |
new daily | 27 |
research question | 27 |
dermatitidis model | 27 |
based learning | 27 |
ligand binding | 27 |
conceptual framework | 27 |
daily life | 27 |
computational resources | 27 |
markov model | 27 |
randomly selected | 27 |
fatty acid | 27 |
infected humans | 27 |
generated using | 27 |
transmission coefficient | 27 |
ligand docking | 27 |
coupled receptor | 27 |
health crisis | 27 |
key factors | 27 |
outbreak originating | 27 |
training samples | 27 |
infection spread | 27 |
data show | 27 |
fitting model | 27 |
brain organoids | 27 |
cell migration | 27 |
water quality | 27 |
removed cases | 27 |
machine translation | 27 |
standard errors | 27 |
scheduling preferences | 27 |
early detection | 27 |
models also | 27 |
built using | 27 |
transition probability | 27 |
ischemic stroke | 27 |
step size | 27 |
virus type | 27 |
potential domestic | 27 |
gene therapy | 27 |
hydrogen bond | 27 |
interactions among | 27 |
culture systems | 27 |
probabilistic model | 27 |
developed countries | 27 |
time variation | 27 |
semseq fd | 27 |
ill patients | 27 |
mass vaccination | 27 |
disease activity | 27 |
normalising constant | 27 |
random graph | 26 |
derived model | 26 |
bottleneck congestion | 26 |
acute phase | 26 |
social distance | 26 |
major role | 26 |
second phase | 26 |
boundary condition | 26 |
random forests | 26 |
adult mice | 26 |
traumatic brain | 26 |
performance computing | 26 |
ct scan | 26 |
reinforced concrete | 26 |
cnn models | 26 |
genome sequencing | 26 |
numerical solution | 26 |
based virtual | 26 |
disease burden | 26 |
mechanistic model | 26 |
traffic flow | 26 |
particle deposition | 26 |
plasma levels | 26 |
good results | 26 |
mast cells | 26 |
virus replication | 26 |
parameter set | 26 |
cellular processes | 26 |
south africa | 26 |
diabetes mellitus | 26 |
fitness function | 26 |
exposed period | 26 |
economic models | 26 |
learning method | 26 |
image data | 26 |
public policy | 26 |
compartment i | 26 |
infection process | 26 |
model developed | 26 |
animal studies | 26 |
must also | 26 |
influenza epidemics | 26 |
part i | 26 |
risk research | 26 |
disease prevention | 26 |
pot var | 26 |
severe illness | 26 |
infectious cases | 26 |
search strategy | 26 |
hm model | 26 |
peptide classification | 26 |
confirmed case | 26 |
following equation | 26 |
dynamic programming | 26 |
fatality ratio | 26 |
recovered people | 26 |
many factors | 26 |
small size | 26 |
urban coastal | 26 |
clinical outcomes | 26 |
ecological niche | 26 |
latin america | 26 |
maximum principle | 26 |
control variable | 26 |
data needs | 26 |
scoring function | 26 |
marine biogeochemistry | 26 |
suicide risk | 26 |
experimental conditions | 26 |
yet infectious | 26 |
time lag | 26 |
network topology | 26 |
first stage | 26 |
order epistasis | 26 |
healthcare facilities | 26 |
vaccine efficacy | 26 |
output variable | 26 |
vast majority | 26 |
active compounds | 26 |
influenza outbreaks | 26 |
viral transmission | 26 |
rna folding | 26 |
several years | 26 |
new therapeutic | 26 |
differential evolution | 26 |
process models | 26 |
research council | 26 |
next days | 26 |
longitudinal data | 26 |
event occurrence | 26 |
decay rate | 26 |
disease severity | 26 |
global scale | 26 |
financial institutions | 26 |
higher risk | 26 |
hospital bed | 26 |
model outputs | 26 |
various models | 26 |
endothelial cell | 26 |
social behavior | 26 |
cases reported | 26 |
mainly due | 26 |
time consuming | 26 |
log returns | 26 |
government response | 26 |
information retrieval | 26 |
square root | 26 |
organic wine | 26 |
host population | 26 |
isolation measures | 26 |
incidence rates | 26 |
time spent | 26 |
simulation study | 26 |
room air | 26 |
ocean biogeochemical | 26 |
clinical trial | 26 |
three classes | 26 |
epidemic forecasting | 26 |
seven days | 26 |
future time | 26 |
dimensional space | 26 |
two steps | 26 |
throughput screening | 26 |
energy transfer | 26 |
following form | 26 |
initial outbreak | 26 |
two equations | 26 |
log transformed | 26 |
best performing | 26 |
innate immunity | 26 |
ml model | 26 |
well understood | 26 |
principal component | 26 |
low levels | 26 |
epidemiological characteristics | 26 |
key features | 26 |
proinflammatory cytokines | 26 |
coronavirus epidemic | 26 |
references therein | 26 |
state vector | 26 |
several days | 26 |
computed using | 26 |
one way | 26 |
forecasting covid | 26 |
ciliary body | 25 |
like cells | 25 |
order differential | 25 |
spatial spread | 25 |
long run | 25 |
carbon cycle | 25 |
accurate model | 25 |
remains constant | 25 |
solution space | 25 |
done using | 25 |
computation time | 25 |
recent research | 25 |
data bank | 25 |
dynamical behavior | 25 |
model reduction | 25 |
close contacts | 25 |
great deal | 25 |
search engine | 25 |
initial exponential | 25 |
monoclonal antibodies | 25 |
influenza infection | 25 |
binding proteins | 25 |
age distribution | 25 |
two major | 25 |
whole genome | 25 |
treatment response | 25 |
early transmission | 25 |
time steps | 25 |
option contract | 25 |
analysis showed | 25 |
publicly reported | 25 |
north american | 25 |
approach using | 25 |
commons attribution | 25 |
published data | 25 |
feature vectors | 25 |
cerebral organoids | 25 |
carbon nanotubes | 25 |
anomaly detection | 25 |
rate parameter | 25 |
will result | 25 |
semantic features | 25 |
random networks | 25 |
feature vector | 25 |
critically ill | 25 |
human populations | 25 |
statistical physics | 25 |
infection peak | 25 |
previous model | 25 |
community detection | 25 |
negatively charged | 25 |
divergence times | 25 |
infected case | 25 |
interstitial pneumonia | 25 |
statistical analyses | 25 |
new information | 25 |
culture medium | 25 |
bayesian estimation | 25 |
operating characteristic | 25 |
incubation time | 25 |
two sets | 25 |
commercially available | 25 |
models include | 25 |
model includes | 25 |
may contribute | 25 |
building energy | 25 |
also provides | 25 |
temporary immunity | 25 |
sufficiently large | 25 |
parameter identification | 25 |
patient data | 25 |
model needs | 25 |
optimization model | 25 |
care homes | 25 |
standard model | 25 |
response surface | 25 |
among individuals | 25 |
translational research | 25 |
last years | 25 |
scientific community | 25 |
clinical deterioration | 25 |
different species | 25 |
previously reported | 25 |
response models | 25 |
single cell | 25 |
human cells | 25 |
strongly agree | 25 |
poisson process | 25 |
human influenza | 25 |
cell adhesion | 25 |
studies show | 25 |
methods based | 25 |
develop symptoms | 25 |
ct image | 25 |
infectious agent | 25 |
perceived severity | 25 |
turning points | 25 |
embedding models | 25 |
novel therapeutic | 25 |
transmission potential | 25 |
data driven | 25 |
distribution models | 25 |
critical cases | 25 |
positive test | 25 |
vitro model | 25 |
empirical evidence | 25 |
models use | 25 |
multiple sources | 25 |
tracer gas | 25 |
time pcr | 25 |
major challenge | 25 |
transition kernel | 25 |
close contact | 25 |
good model | 25 |
pathogenic avian | 25 |
hidden layer | 25 |
peak infection | 25 |
highest accuracy | 25 |
infections caused | 25 |
used data | 25 |
world networks | 25 |
time frame | 25 |
almost every | 25 |
higher level | 25 |
cxr images | 25 |
mean time | 25 |
basic sir | 25 |
human skin | 25 |
relaxed clock | 25 |
also possible | 25 |
count data | 25 |
time window | 25 |
liver injury | 25 |
laboratory findings | 25 |
care home | 25 |
ms ms | 25 |
gold standard | 25 |
order derivative | 25 |
epidemics using | 24 |
simple exponential | 24 |
phylogenetic trees | 24 |
modeling framework | 24 |
ebola epidemic | 24 |
three days | 24 |
rd february | 24 |
markov chains | 24 |
simian immunodeficiency | 24 |
larger number | 24 |
infection models | 24 |
mean duration | 24 |
calcium phosphate | 24 |
supplementary materials | 24 |
individual level | 24 |
likely due | 24 |
ab initio | 24 |
around day | 24 |
branch length | 24 |
using various | 24 |
chikungunya virus | 24 |
flow rate | 24 |
best fitting | 24 |
several different | 24 |
cotton rats | 24 |
young adults | 24 |
close proximity | 24 |
gaussian process | 24 |
best models | 24 |
error function | 24 |
images using | 24 |
mild symptoms | 24 |
care workers | 24 |
first level | 24 |
influencing factors | 24 |
th century | 24 |
index case | 24 |
many models | 24 |
fluorescence microscopy | 24 |
target dataset | 24 |
tested positive | 24 |
different parameters | 24 |
will likely | 24 |
tyrosine kinase | 24 |
spanish flu | 24 |
global epidemic | 24 |
actin cytoskeleton | 24 |
certain degree | 24 |
results using | 24 |
option price | 24 |
antimicrobial activity | 24 |
risk models | 24 |
two states | 24 |
negative impact | 24 |
equation models | 24 |
lipid membranes | 24 |
particularly useful | 24 |
transcription factors | 24 |
primate model | 24 |
cell membranes | 24 |
prior probability | 24 |
dengue transmission | 24 |
fractional model | 24 |
economic activity | 24 |
threshold exceedances | 24 |
mathematical formulation | 24 |
parallel training | 24 |
life sciences | 24 |
household quarantine | 24 |
model adequacy | 24 |
medical research | 24 |
economic consequences | 24 |
gastric cancer | 24 |
model states | 24 |
across multiple | 24 |
asymptomatic infected | 24 |
high dose | 24 |
many studies | 24 |
infection curves | 24 |
one study | 24 |
data generated | 24 |
ultimate goal | 24 |
will give | 24 |
global dynamics | 24 |
experimentally determined | 24 |
phylogenetic analysis | 24 |
may take | 24 |
second model | 24 |
mild cases | 24 |
indel information | 24 |
differentially expressed | 24 |
dcm parameters | 24 |
relationships among | 24 |
prostate cancer | 24 |
th april | 24 |
optimal parameters | 24 |
banking system | 24 |
predictive validity | 24 |
caputo fractional | 24 |
functional theory | 24 |
national institute | 24 |
transmission probability | 24 |
van den | 24 |
markov models | 24 |
age classes | 24 |
language understanding | 24 |
mice developed | 24 |
rna polymerase | 24 |
prediction task | 24 |
may include | 24 |
last two | 24 |
computer simulation | 24 |
authors used | 24 |
free parameters | 24 |
left side | 24 |
life span | 24 |
transmitted diseases | 24 |
many researchers | 24 |
time prediction | 24 |
molecular descriptors | 24 |
will decrease | 24 |
years ago | 24 |
protein data | 24 |
accurately predict | 24 |
infected animals | 24 |
resulting model | 24 |
tumor necrosis | 24 |
generic models | 24 |
land use | 24 |
network structures | 24 |
inflammatory cells | 24 |
lockdown period | 23 |
infection data | 23 |
diffusion processes | 23 |
days postexposure | 23 |
hospital admissions | 23 |
deployment models | 23 |
interest rate | 23 |
asymptomatic infectious | 23 |
new drug | 23 |
lstm network | 23 |
hydrogen bonds | 23 |
given country | 23 |
control policies | 23 |
false positives | 23 |
change scenarios | 23 |
single models | 23 |
data determined | 23 |
data structure | 23 |
digital contact | 23 |
model must | 23 |
also applied | 23 |
public domain | 23 |
recent developments | 23 |
hawkes processes | 23 |
seird model | 23 |
small intestine | 23 |
digital health | 23 |
simulation parameters | 23 |
adverse event | 23 |
gives rise | 23 |
effective contact | 23 |
regenerative medicine | 23 |
every individual | 23 |
mentioned earlier | 23 |
esir model | 23 |
recommendation systems | 23 |
systems science | 23 |
disease symptoms | 23 |
will require | 23 |
intelligent adversary | 23 |
clinical course | 23 |
candidate models | 23 |
google scholar | 23 |
serious game | 23 |
generative adversarial | 23 |
peak number | 23 |
case studies | 23 |
graph convolutional | 23 |
risk groups | 23 |
will develop | 23 |
ensemble methods | 23 |
dose dependent | 23 |
analysis revealed | 23 |
population densities | 23 |
daily reported | 23 |
different approaches | 23 |
transmission coefficients | 23 |
riley equation | 23 |
time unit | 23 |
behavioral changes | 23 |
shortest path | 23 |
per se | 23 |
great potential | 23 |
health management | 23 |
null hypothesis | 23 |
current pandemic | 23 |
contact structure | 23 |
reporting rate | 23 |
whole population | 23 |
day period | 23 |
employed individuals | 23 |
spatial variation | 23 |
incidence data | 23 |
red blood | 23 |
individuals become | 23 |
high school | 23 |
high number | 23 |
pseudoknot structures | 23 |
air passenger | 23 |
acid sequences | 23 |
prediction tools | 23 |
linear growth | 23 |
climate migration | 23 |
new technologies | 23 |
infected mice | 23 |
available online | 23 |
lung organoids | 23 |
fatty acids | 23 |
different model | 23 |
modelling approaches | 23 |
reproductive rate | 23 |
scientificreports www | 23 |
model describes | 23 |
current status | 23 |
additional data | 23 |
experiments show | 23 |
mean values | 23 |
healthcare systems | 23 |
airway organoids | 23 |
virus strain | 23 |
culture media | 23 |
transition rate | 23 |
cell activation | 23 |
epidemic process | 23 |
cmip models | 23 |
clinical use | 23 |
fitting parameters | 23 |
frailty model | 23 |
wound healing | 23 |
initial population | 23 |
particle swarm | 23 |
sequential data | 23 |
learning framework | 23 |
time distribution | 23 |
diversity constraint | 23 |
blot analysis | 23 |
maximum plateau | 23 |
vivo models | 23 |
important issue | 23 |
main text | 23 |
internal consistency | 23 |
coronary artery | 23 |
birth weight | 23 |
time required | 23 |
alternative models | 23 |
staphylococcus aureus | 23 |
study using | 23 |
last decade | 23 |
nucleic acids | 23 |
protein folding | 23 |
asymptotic stability | 23 |
th day | 23 |
one year | 23 |
total fatalities | 23 |
human body | 23 |
slightly different | 23 |
respiratory deposition | 23 |
constant population | 23 |
periodontal disease | 23 |
given model | 23 |
independent variable | 23 |
exclusion criteria | 23 |
option pricing | 23 |
viral loads | 23 |
recent covid | 23 |
pig model | 23 |
declarative deployment | 23 |
genome editing | 23 |
two decades | 23 |
dose data | 23 |
social sciences | 23 |
experimental study | 23 |
reciprocal sign | 23 |
metabolic pathways | 23 |
current generation | 22 |
macro level | 22 |
exposed class | 22 |